Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)

NAActive, not recruitingINTERVENTIONAL
Enrollment

33,948

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2027

Conditions
Esophageal Squamous Cell CarcinomaDysplasia
Interventions
PROCEDURE

Endoscopic Screening

"1. Upper G.I. endoscopic examination with Lugols Iodine in esophagus~2. Biopsy at the visually abnormal sites~3. Pathologic examination of all biopsy tissue specimens~4. Subsequent re-examination and further medical services among individuals who already have high-grade lesions found at screening.~5. Advises of endoscopic or surgical treatment will be given to participants who are diagnosed of high grade upper G.I. lesions."

Trial Locations (1)

100142

Laboratory of genetics, Peking University cancer Hospital and institute, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT01688908 - Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC) | Biotech Hunter | Biotech Hunter